Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17–Dependent Protection against Mycobacterium tuberculosis Infection
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.